JCR Pharmaceuticals to Showcase at the 15th International Congress on Inborn Errors of Metabolism (ICIEM) 2025

JCR Pharmaceuticals Presentation: JCR Pharmaceuticals will present data at the 15th International Congress of Inborn Errors of Metabolism (ICIEM) 2025 in Kyoto, Japan, showcasing investigational therapies and their proprietary J-Brain Cargo® technology.

Presentation Details: The company will feature one oral presentation and four poster presentations, focusing on the therapeutic effects of pabinafusp alfa and JR-446, as well as long-term safety and efficacy data related to mucopolysaccharidosis type II.

About ICIEM: The ICIEM is a significant international conference held every four years that gathers professionals to discuss advancements in the study and treatment of inherited metabolic disorders.

Company Overview: JCR Pharmaceuticals specializes in developing treatments for rare diseases and has a history of over 50 years in Japan, with ongoing efforts to expand its global presence and improve patient outcomes through innovative therapies.